
Cyclisis PF 0.05%w/v Eye Drop
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Ciclosporin (0.05% w/v)
Overview Cyclisis PF 0.05%w/v Eye Drop
Dry eye sufferers may find relief with Cyclisis PF 0.05% w/v Eye Drops. These drops combat dryness by reducing eye inflammation, thus stimulating tear production and alleviating discomfort. Ensure the bottle's seal is intact before initial use. Always wash your hands and shake the bottle vigorously before each application. Remove contact lenses before administering and wait at least 15 minutes for reinsertion. Significant improvement may take several weeks; continue use as directed. While blurred vision and eye burning are common, temporary side effects, avoid driving if vision is impaired. Report persistent discomfort to your physician. Interaction with other oral or injectable medications is unlikely. If prior use of similar eye drops resulted in an allergic reaction, consult your doctor before starting treatment. Pregnant or breastfeeding individuals should not use this product.
Uses of Cyclisis PF 0.05%w/v Eye Drop
Ocular dryness
Major Benefits of Cyclisis PF 0.05%w/v Eye Drop:
Apply this medication externally only. Administer as directed by your physician, following the prescribed dosage and treatment schedule. Always consult the product label for application instructions prior to use. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.
Common Side effects of Cyclisis PF 0.05%w/v Eye Drop:
- Blurred vision
- Burning sensation in eye
- Headache
- High blood pressure
- Renal dysfunction
- Tremors
- Increased glucose level in blood
- Paresthesia (tingling or pricking sensation)
- Acne
- Decreased white blood cell count
- Increased levels of blood fat
- Decreased appetite
- Increased uric acid level in blood
- Electrolyte imbalance
- Convulsion
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Gastrointestinal disturbance
- Gingival hyperplasia
- Stomach ulcer
- Abnormal liver function
- Excessive hair growth on face
- Hypertrichosis (excessive hair growth)
- Muscle cramp
- Muscle pain
- Fever
- Fatigue
How to use Cyclisis PF 0.05%w/v Eye Drop:
Apply this medication topically only. Administer as directed by your physician, adhering to the prescribed dosage and timeframe. Consult the product label for detailed application instructions prior to use. Position the dropper near the eye, avoiding contact, and gently dispense the medication into the lower conjunctival sac. Remove any excess fluid.
How Cyclisis PF 0.05%w/v Eye Drop works:
Cyclisis PF 0.05% w/v ophthalmic solution is an immunomodulator promoting tear secretion in patients with persistent dry eye. Its mechanism involves the reduction of ocular inflammation, thereby facilitating tear film formation and alleviating dryness-related discomfort.
SAFETY ADVICE
AlcoholNone
No drug interactions identified.
PregnancyCONSULT YOUR DOCTOR
The use of Cyclisis PF 0.05% w/v Eye Drops during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation is contraindicated with the use of Cyclisis PF 0.05% w/v eye drops due to potential infant toxicity.
DrivingCONSULT YOUR DOCTOR
The effect of Cyclisis PF 0.05% w/v Eye Drops on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyNone
No drug interaction detected.
LiverNone
No known drug interactions.
What if you forget to take Cyclisis PF 0.05%w/v Eye Drop :
Should you forget a dose of Cyclisis PF 0.05% w/v Eye Drops, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cyclisis PF 0.05%w/v Eye Drop
| Label | Value |
|---|---|
| Chemical Type | Cyclosporine Analog |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Action Class | Calcineurin inhibitor immunosuppressants |
